BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 42 filers reported holding BIND THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,000 | -66.7% | 1,555 | 0.0% | 0.00% | – |
Q1 2016 | $3,000 | -25.0% | 1,555 | -9.6% | 0.00% | – |
Q4 2015 | $4,000 | -50.0% | 1,720 | 0.0% | 0.00% | – |
Q3 2015 | $8,000 | -20.0% | 1,720 | 0.0% | 0.00% | – |
Q2 2015 | $10,000 | -77.3% | 1,720 | -78.4% | 0.00% | – |
Q1 2015 | $44,000 | +144.4% | 7,980 | +139.3% | 0.00% | – |
Q4 2014 | $18,000 | -61.7% | 3,335 | -39.1% | 0.00% | – |
Q3 2014 | $47,000 | -33.8% | 5,476 | +1.7% | 0.00% | – |
Q2 2014 | $71,000 | +18.3% | 5,382 | +8.4% | 0.00% | – |
Q1 2014 | $60,000 | +46.3% | 4,964 | +79.1% | 0.00% | – |
Q4 2013 | $41,000 | – | 2,771 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 2,018,253 | $9,001,000 | 6.13% |
FNY Managed Accounts LLC | 30,000 | $133,800,000 | 0.37% |
Rhenman & Partners Asset Management AB | 133,535 | $596,000 | 0.10% |
THOMPSON DAVIS & CO., INC. | 4,500 | $20,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 26,000 | $116,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,593 | $373,000 | 0.01% |
VANGUARD GROUP INC | 5,488,396 | $177,885,000 | 0.01% |
Alyeska Investment Group, L.P. | 114,786 | $512,000 | 0.01% |
Renaissance Technologies | 269,300 | $1,201,000 | 0.00% |
PRINCIPAL FINANCIAL GROUP INC | 324,900 | $1,449,000 | 0.00% |